Oncothyreon Innovating Targeted Cancer Therapies
Investors

Overview

We are committed to serving the best interests of our shareholders. If you require assistance or have questions regarding the key shareholder information and financial reports available here please contact us.

NASDAQ: ONTY
1.90
+ 0.10 (+5.56%)
4:00 PM ET on Dec 22, 2014
Delayed at least 20 minutes.